The manufacturing and licensing agreement with TTK, a major player in the Indian condom market, represents a further step towards global commercialisation of CSD500, Futura’s novel erectogenic condom. TTK has extensive experience in cost-efficient condom manufacture, having previously supplied Durex condoms to SSL International globally prior to its acquisition by Reckitt. In addition, CSD500 in our view represents an excellent fit for TTK’s fastgrowing SKORE condom brand in India. We maintain a ....
13 Jun 2016
Manufacturing and licensing deal in India
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Manufacturing and licensing deal in India
Futura Medical plc (FUM:LON) | 35.7 -0.1 (-0.6%) | Mkt Cap: 107.7m
- Published:
13 Jun 2016 -
Author:
Dr Jens Lindqvist -
Pages:
3
The manufacturing and licensing agreement with TTK, a major player in the Indian condom market, represents a further step towards global commercialisation of CSD500, Futura’s novel erectogenic condom. TTK has extensive experience in cost-efficient condom manufacture, having previously supplied Durex condoms to SSL International globally prior to its acquisition by Reckitt. In addition, CSD500 in our view represents an excellent fit for TTK’s fastgrowing SKORE condom brand in India. We maintain a ....